StockData
Cresco Labs Inc. logo

Cresco Labs Inc. (CRLBF) stock

CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Cresco Labs ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was $20.73M, down 87.5% from the year before. The highest annual figure on record is $166.39M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.73M-87.5%
FY2024Dec 31, 2024$166.39M–
FY2023Dec 31, 2023-$25.31M–
FY2022Dec 31, 2022-$32.37M–
FY2021Dec 31, 2021-$178.71M-2246.4%
FY2020Dec 31, 2020$8.33M–
FY2019Dec 31, 2019-$22.35M–

More Cresco Labs figures

See a number that looks wrong?